Beliefs, motivations, and opinions about moderate drinking: a cross-sectional survey.

Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Family medicine (Impact Factor: 0.85). 04/2008; 40(3):188-95.
Source: PubMed

ABSTRACT The relationship of moderate alcohol use and health remains controversial and uncertain. How physicians and patients react to this uncertainty is unknown.
We surveyed outpatients at a single urban medical center that provides primary and tertiary care. Participants completed a self-administered anonymous survey regarding their medical history, usual alcohol consumption, and preferences and opinions regarding moderate drinking, defined as a drink every 1 to 2 days. All English-speaking individuals ages 21 years and older were eligible.
A total of 878 outpatients participated, with a response rate of 79%. The median age was 47 years, and 57% were women. Approximately 60% of drinkers and 35% of abstainers agreed with the statement that moderate drinking is a healthy activity and that it is safe for most people. About one third of participants cited possible health benefits as part of their motivation for drinking alcohol. Those who cited health benefits tended to be older, consumed alcohol more frequently but with a lower quantity per drinking day, and were more likely to have a history of coronary heart disease. Only about 10% of participants identified breast cancer as a possible risk of moderate drinking. When asked whether they would be willing to consume one drink every 1--2 days if their doctor so recommended, 41% of abstainers and 72% of all drinkers were willing to do so.
A substantial number of medical outpatients cite health benefits as a motivation for drinking alcohol and a willingness to drink alcohol regularly if so recommended by a physician, although few recognize health risks from drinking alcohol.

  • Source
    Web Ecology 01/2008; 8:103–105. DOI:10.5194/we-8-103-2008
  • [Show abstract] [Hide abstract]
    ABSTRACT: The majority view among alcohol epidemiologists is that the lower coronary heart disease mortality observed in moderate drinkers is probably evidence for a protective effect of moderate drinking. In this paper I critically discuss the debate about what type of information, if any, should be provided to the public about the putative coronary heart disease benefits of moderate alcohol use. Most opposition to informing the public about these putative benefits is based on the fear that such advice will increase per capita alcohol consumption and therefore alcohol-related harm. It is unclear how well-based these concerns are. In the interim, the alcohol industry has communicated these putative benefits to the public. There is a case for including some information on these putative benefits in specific safer drinking guidelines for middle-aged and older drinkers that: clearly conveys the remaining uncertainty about the benefits of moderate drinking, emphasises the conditional nature of any such benefits, and stresses the need to balance the potential benefits against the increased sensitivity of older adults to other adverse effects of alcohol, and the increased risk of interactions between alcohol and other medications used by older adults.
    Drug and Alcohol Review 09/2011; 31(2):194-7. DOI:10.1111/j.1465-3362.2011.00345.x · 1.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT:   Most, but not all, epidemiological studies suggest a cardioprotective association for low to moderate average alcohol consumption. The objective was to quantify the dose-response relationship between average alcohol consumption and ischaemic heart disease (IHD) stratified by sex and IHD end-point (mortality versus morbidity).   A systematic search of published studies using electronic databases (1980-2010) identified 44 observational studies (case-control or cohort) reporting a relative risk measure for average alcohol intake in relation to IHD risk. Generalized least-squares trend models were used to derive the best-fitting dose-response curves in stratified continuous meta-analyses. Categorical meta-analyses were used to verify uncertainty for low to moderate levels of consumption in comparison to long-term abstainers.   The analyses used 38,627 IHD events (mortality or morbidity) among 957,684 participants. Differential risk curves were found by sex and end-point. Although some form of a cardioprotective association was confirmed in all strata, substantial heterogeneity across studies remained unexplained and confidence intervals were relatively wide, in particular for average consumption of one to two drinks/day.   A cardioprotective association between alcohol use and ischaemic heart disease cannot be assumed for all drinkers, even at low levels of intake. More evidence on the overall benefit-risk ratio of average alcohol consumption in relation to ischaemic heart disease and other diseases is needed in order to inform the general public or physicians about safe or low-risk drinking levels.
    Addiction 01/2012; 107(7):1246-60. DOI:10.1111/j.1360-0443.2012.03780.x · 4.60 Impact Factor


Available from